A Pilot Study of Aerosolized Amiloride for the Treatment of Lung Disease in Cystic Fibrosis

New England Journal of Medicine

Volumn 322, Issue 17, 1990, Pages 1189-1194

  Knowles, Michael R ^a   Church, Nina L ^a   Waltner, William E ^a   Yankaskas, James R ^a   Gilligan, Peter ^a   King, Malcolm ^b   Edwards, Lloyd J ^a   Helms, Ronald W ^a   Boucher, Richard C ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG DISEASE; PRIORITY JOURNAL; SPUTUM; VISCOELASTICITY;

ABSORPTION; ADOLESCENT; ADULT; AEROSOLS; AMILORIDE; CYSTIC FIBROSIS; DOUBLE-BLIND METHOD; FEMALE; HUMAN; LUNG DISEASES; MALE; MUCOCILIARY CLEARANCE; PILOT PROJECTS; RANDOMIZED CONTROLLED TRIALS; SODIUM; SODIUM CHANNELS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VITAL CAPACITY;

EID: 0025236867     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199004263221704     Document Type: Article

References (31)

1. Boucher RC, Stutts MJ, Knowles MR, Cantley L, Gatzy JT. Na+ transport in cystic fibrosis respiratory epithelia: abnormal basal rate and response to adenylate cyclase activation. J Clin Invest 1986; 78: 1245–52.
2. Boucher RC, Cotton CU, Gatzy JT, Knowles MR, Yankaskas JR. Evidence for reduced Cl− permeability and increased Na+ permeability in cystic fibrosis human primary cell cultures. J Physiol (Lond) 1988; 405: 77–103.
3. Knowles M, Gatzy J, Boucher R. Relative ion permeability of normal and cystic fibrosis nasal epithelium. J Clin Invest 1983; 71: 1410–7.
4. Frizzell RA, Rechkemmer G, Shoemaker RL. Altered regulation of airway epithelial cell chloride channels in cystic fibrosis. Science 1986; 233: 558–60.
5. Shoumacher RA, Shoemaker RL, Halm DR, Tallant EA, Wallace RW, Frizzell RA. Phosphorylation fails to activate chloride channels from cystic fibrosis airway cells. Nature 1987; 330: 752–4.
6. Li M, McCann JD, Liedtke CM, Nairn Achéal, Greengard P, Welsh MJ. Cyclic AMP-dependent protein kinase opens chloride channels in normal but not cystic fibrosis airway epithelium. Nature 1988; 331: 358–60.
7. Potter JL, Matthews LW, Spector S, Lemm J. Studies on pulmonary secretions. II. Osmolality and the ionic environment of pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy. Am Rev Respir Dis 1967; 96: 83–7.
8. Newhouse MT, Rossman CM, Dolovich J, Dolovich MB, Wilson WM. Impairment of mucociliary transport in cystic fibrosis. Mod Probl Paediatr 1976; 19: 190–8.
9. Wood RE, Boat TF, Doershuk CF. Cystic fibrosis. Am Rev Respir Dis 1976; 113: 833–78.
10. Knowles M, Murray G, Shallal J, et al. Bioelectric properties and ion flow across excised human bronchi. J Appl Physiol 1984; 56: 868–77.
11. Knowles M, Gatzy J, Boucher R. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med 1981; 305: 1489–95.
12. Waltner WE, Boucher RC, Gatzy JT, Knowles MR. Pharmacotherapy of airway disease in cystic fibrosis. TIPS 1987; 8: 316–20.
13. Puchelle E, Tournier JM, Zahm JM, Sadoul P. Rheology of sputum collected by a simple technique limiting salivary contamination. J Lab Clin Med 1984; 103: 347–53.
14. Waltner WE, Church NL, Gatzy JT, Boucher RC, Knowles MR. Toxicity and pharmacokinetics of acute amiloride aerosol in normal and cystic fibrosis subjects. Cystic Fibrosis Club Abstr 1986; 27: 121. abstract.
15. Waltner. Deposition, pharmacokinetics, and toxicity of amiloride aerosol in normal and cystic fibrosis (CF) subjects. Am Rev Respir Dis 1987; 135: Suppl: A288. abstract.
16. American Thoracic Society. Standardization of spirometry — 1987 update. Am Rev Respir Dis 1987; 136: 1285–98.
17. Hodinka RL, Gilligan P, Gage P, Wait K, Knowles M. Quantitative bacteriology of sputum from cystic fibrosis patients. Presented at the 84th Annual Meeting of the American Society for Microbiology, Miami Beach, Fla., May 8–13, 1988. abstract.
18. Høiby N. Microbiology of lung infections in cystic fibrosis patients. Acta Paediatr Scand Suppl 1982; 301: 33–54.
19. King M, Macklem PT. Rheological properties of microliter quantities of normal mucus. J Appl Physiol 1977; 42: 797–802.
20. Brasfield D, Hicks G, Soong S, Tiller RE. The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics 1979; 63: 24–29.
21. Jeanneret-Grosjean A, King M, Michoud MC, Lioté H, Amyot R. Sampling technique and rheology of human tracheobronchial mucus. Am Rev Respir Dis 1988; 137: 707–10.
22. King M, Brock G, Lundell C. Clearance of mucus by simulated cough. J Appl Physiol 1985; 58: 1776–82.
23. Demedts M. Assessment of airway secretions by pulmonary function tests. Eur J Respir Dis 1987; 71: 330–3.
24. Mentz WM, Brown JB, Friedman M, Stutts MJ, Gatzy JT, Boucher RC. Deposition, clearance, and effects of aerosolized amiloride in sheep airways. Am Rev Respir Dis 1986; 134: 938–43.
25. Boucher RC, James MK, Friedman M, Fullton J, Pimmel R, Gatzy JT. Acute cardiovascular and pulmonary effects of intravenous and aerosolized amiloride in the dog. Toxicol Appl Pharmacol 1987; 87: 264–75.
26. Smith AL, Redding G, Doershuk C, et al. Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis. J Pediatr 1988; 112: 547–54.
27. Köhler D, App E, Schmitz-Schumann M, Würtemberger G, Matthys H. Inhalation of amiloride improves the mucociliary and the cough clearance in patients with cystic fibrosis. Eur J Respir Dis Suppl 1986; 146: 319–26.
28. Cohn RC, Jacobs M, Aronoff SC In vitro activity of amiloride combined with tobramycin against Pseudomonas isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 1988; 32: 395–6.
29. Lisker A, Gilligan P, Wait K, Knowles M. In vitro activity of amiloride against bacteria isolated from patients with cystic fibrosis. Pediatr Pulmonol 1987; 3: Suppl: 126. abstract.
30. George M, Knowles M, Gilligan P. In vitro activity of amiloride congeners against bacteria isolated from patients with cystic fibrosis (CF). Presented at the 84th Annual Meeting of the American Society for Microbiology, Miami Beach, Fla., May 8–13, 1988. abstract.
31. King M. Mucus, mucociliary clearance and coughing. In: Bates DV, ed. Respiratory function in disease. 3rd ed. Philadelphia: W.B. Saunders, 1989:69–78.